Manulife Holdings Berhad (KLSE:MANULFE)
2.250
0.00 (0.00%)
At close: Dec 9, 2025
Manulife Holdings Berhad Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Premiums & Annuity Revenue | 464.64 | 439.42 | 360.21 | 316.17 | 1,003 | 920.81 | Upgrade |
Total Interest & Dividend Income | 37.36 | -38.29 | -7.82 | 75.85 | 209.03 | 187.1 | Upgrade |
Gain (Loss) on Sale of Investments | 21.37 | 134.04 | 54.91 | -57.7 | 137.46 | 153.27 | Upgrade |
Other Revenue | 157.31 | 160.82 | 122.95 | 119.11 | 150.27 | 109.52 | Upgrade |
| 680.69 | 695.99 | 530.26 | 453.43 | 1,500 | 1,371 | Upgrade | |
Revenue Growth (YoY) | -0.12% | 31.25% | 16.94% | -69.77% | 9.43% | 0.94% | Upgrade |
Policy Benefits | 226.95 | 271.74 | 239.28 | 270.06 | 956.34 | 971.34 | Upgrade |
Policy Acquisition & Underwriting Costs | 231.27 | 170.28 | 112.32 | 66.81 | 211.33 | 114.38 | Upgrade |
Selling, General & Administrative | 61.33 | 63.72 | 64.44 | 63.34 | 211.23 | 208.76 | Upgrade |
Other Operating Expenses | 20.18 | 4.81 | 0.97 | - | 5.08 | 2.43 | Upgrade |
Total Operating Expenses | 539.73 | 510.55 | 417.01 | 400.2 | 1,385 | 1,299 | Upgrade |
Operating Income | 140.95 | 185.45 | 113.25 | 53.23 | 115.07 | 71.79 | Upgrade |
Interest Expense | -0.08 | -0.09 | -0.11 | -0.09 | -0.02 | -0.02 | Upgrade |
Currency Exchange Gain (Loss) | - | - | - | - | 8 | -2.37 | Upgrade |
EBT Excluding Unusual Items | 140.88 | 185.36 | 113.14 | 53.14 | 123.05 | 69.41 | Upgrade |
Asset Writedown | - | - | - | - | -0.05 | - | Upgrade |
Pretax Income | 140.88 | 185.36 | 113.14 | 53.14 | 122.99 | 69.41 | Upgrade |
Income Tax Expense | 44.21 | 53.99 | 29.27 | 19.05 | 36.03 | 30.6 | Upgrade |
Earnings From Continuing Ops. | 96.67 | 131.37 | 83.87 | 34.08 | 86.96 | 38.82 | Upgrade |
Minority Interest in Earnings | - | - | - | -10.65 | - | -0 | Upgrade |
Net Income | 96.67 | 131.37 | 83.87 | 23.44 | 86.96 | 38.81 | Upgrade |
Preferred Dividends & Other Adjustments | 6.03 | 22.5 | -4.87 | - | - | - | Upgrade |
Net Income to Common | 90.63 | 108.87 | 88.74 | 23.44 | 86.96 | 38.81 | Upgrade |
Net Income Growth | -35.09% | 56.62% | 257.88% | -73.05% | 124.06% | 48.51% | Upgrade |
Shares Outstanding (Basic) | 226 | 222 | 218 | 214 | 209 | 204 | Upgrade |
Shares Outstanding (Diluted) | 226 | 222 | 218 | 214 | 209 | 204 | Upgrade |
Shares Change (YoY) | 2.52% | 1.91% | 1.85% | 2.18% | 2.40% | 0.88% | Upgrade |
EPS (Basic) | 0.40 | 0.49 | 0.41 | 0.11 | 0.42 | 0.19 | Upgrade |
EPS (Diluted) | 0.40 | 0.49 | 0.41 | 0.11 | 0.42 | 0.19 | Upgrade |
EPS Growth | -32.91% | 20.39% | 271.80% | -73.63% | 118.82% | 47.22% | Upgrade |
Free Cash Flow | -47.07 | 102.11 | 82.9 | 26.75 | 40.78 | 2.71 | Upgrade |
Free Cash Flow Per Share | -0.21 | 0.46 | 0.38 | 0.13 | 0.20 | 0.01 | Upgrade |
Dividend Per Share | 0.080 | 0.080 | 0.070 | 0.070 | 0.070 | 0.070 | Upgrade |
Dividend Growth | 14.29% | 14.29% | - | - | - | - | Upgrade |
Operating Margin | 20.71% | 26.65% | 21.36% | 11.74% | 7.67% | 5.24% | Upgrade |
Profit Margin | 13.31% | 15.64% | 16.74% | 5.17% | 5.80% | 2.83% | Upgrade |
Free Cash Flow Margin | -6.92% | 14.67% | 15.63% | 5.90% | 2.72% | 0.20% | Upgrade |
EBITDA | 153.77 | 197.26 | 120.31 | 58.21 | 126.99 | 80.85 | Upgrade |
EBITDA Margin | 22.59% | 28.34% | 22.69% | 12.84% | 8.47% | 5.90% | Upgrade |
D&A For EBITDA | 12.82 | 11.82 | 7.06 | 4.98 | 11.93 | 9.06 | Upgrade |
EBIT | 140.95 | 185.45 | 113.25 | 53.23 | 115.07 | 71.79 | Upgrade |
EBIT Margin | 20.71% | 26.65% | 21.36% | 11.74% | 7.67% | 5.24% | Upgrade |
Effective Tax Rate | 31.38% | 29.13% | 25.87% | 35.85% | 29.30% | 44.08% | Upgrade |
Revenue as Reported | - | - | - | - | 1,508 | 1,380 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.